Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
0.5281
-0.0885 (-14.35%)
At close: Nov 13, 2026, 4:00 PM EST
0.5349
+0.0068 (1.29%)
After-hours: Nov 13, 2026, 6:16 PM EST
CELZ Market Cap
CELZ has a market cap or net worth of $3.48 million as of November 13, 2026. It is the 45,611th most valuable company in the world and the 6,034th biggest in the United States. Its market cap has decreased by 58.05% in one year.
Market Cap
3.48M
Enterprise Value
-3.35M
1-Year Change
-58.05%
Global Rank
Country Rank
#6,034 United States
Category
ChartMarket Cap Chart
Since December 3, 2021, CELZ's market cap has decreased from $16.10M to $3.48M, a decrease of -78.38%. That is a compound annual growth rate of -26.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 4.70M | -7.84% |
| Dec 31, 2025 | 5.10M | 27.50% |
| Dec 31, 2024 | 4.00M | -37.50% |
| Dec 29, 2023 | 6.40M | 18.52% |
| Dec 30, 2022 | 5.40M | -66.46% |
| Dec 31, 2021 | 16.10M | - |
| Dec 3, 2021 | 16.10M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Niki BioSolutions | 4.61M |
| AIM ImmunoTech | 4.52M |
| Xenetic Biosciences | 4.37M |
| PharmaCyte Biotech | 4.28M |
| Alaunos Therapeutics | 4.09M |
| Skye Bioscience | 4.07M |
| NuCana | 4.05M |
| Imunon | 4.04M |